Hosptial for Special Surgery, New York, New York, USA.
Department of Orthopaedic Surgery, School of Medicine, Teikyo University, Tokyo, Japan.
Am J Sports Med. 2018 Mar;46(3):642-648. doi: 10.1177/0363546517739606. Epub 2017 Nov 16.
Microfracture is the most common cartilage-reparative procedure for the treatment of osteochondral lesions of the talus (OLTs). Damage to the subchondral bone (SCB) during microfracture may irreversibly change the joint-loading support of the ankle, leading to reparative fibrocartilage degradation over time.
To investigate the morphological change in the SCB after microfracture for OLT by developing a novel magnetic resonance imaging (MRI) scoring system specifically for evaluating the SCB. Furthermore, this study assesses the influence of the morphological changes of the SCB on clinical outcomes based on the new score.
Case series; Level of evidence, 4.
Forty-two patients who underwent microfracture for OLT were included. An SCB Health (SCBH) scoring system was developed according to the amount of edema, subchondral cyst diameter, and qualitative and thickness change in the SCB, with a total score of 12 indicating normal SCB. MRI was obtained postoperatively from 6 months to 1 year, 1 to 2 years, 2 to 4 years, and 4 to 6 years. The Foot and Ankle Outcome Score (FAOS) was evaluated preoperatively and at 2 years and final follow-up.
The mean patient age was 38.4 ± 15.6 years, with a mean follow-up of 51.7 ± 22.8 months. The mean FAOS improved significantly from 57.8 ± 14.4 preoperatively to 84.3 ± 7.2 at 24 months ( P < .001) and decreased to a final mean value of 77.1 ± 12.6 ( P < .001). The mean SCBH score decreased from 8.6 ± 1.9 preoperatively to 7.1 ± 1.8 on the first follow-up MRI ( P < .001) and significantly decreased to 5.9 ± 2.3 on the fourth follow-up MRI ( P < .001). Subchondral cysts were noticeably worse at the fourth follow-up MRI than at the first and second ( P < .001, P = .006, respectively). There was a positive correlation between the final FAOS and the SCBH score on the third and fourth follow-up MRI ( r = 0.55, P < .001; r = 0.70, P < .001, respectively), but no correlation was found on the first and second follow-up.
The SCBs following microfracture for OLT were not restored at midterm follow-up. There was a significant decrease of the overall SCBH score over time. Noticeably, subchondral cysts deteriorated over time consistently. In addition, the SCBH score at midterm follow-up was positively correlated with clinical outcomes. Lasting morphological changes in the SCB may be indicative of longer-term failure of the microfracture procedure.
微骨折术是治疗距骨骨软骨病变(OLTs)最常用的软骨修复程序。微骨折过程中对软骨下骨(SCB)的损伤可能会不可逆地改变踝关节的关节负荷支撑,导致修复性纤维软骨随时间降解。
通过开发一种专门用于评估 SCB 的新的磁共振成像(MRI)评分系统,研究微骨折治疗 OLT 后 SCB 的形态变化。此外,本研究根据新评分评估 SCB 形态变化对临床结果的影响。
病例系列;证据水平,4 级。
纳入 42 例接受 OLT 微骨折治疗的患者。根据水肿量、软骨下囊肿直径以及 SCB 的定性和厚度变化,制定了 SCB 健康(SCBH)评分系统,总分为 12 分表示 SCB 正常。术后 6 个月至 1 年、1 年至 2 年、2 年至 4 年和 4 年至 6 年进行 MRI 检查。术前和 2 年及最终随访时采用足踝结局评分(FAOS)进行评估。
患者平均年龄为 38.4 ± 15.6 岁,平均随访 51.7 ± 22.8 个月。FAOS 评分从术前的 57.8 ± 14.4 显著提高至 24 个月时的 84.3 ± 7.2(P <.001),并在最终随访时降至 77.1 ± 12.6(P <.001)。SCBH 评分从术前的 8.6 ± 1.9 降至首次随访时的 7.1 ± 1.8(P <.001),在第四次随访时明显降至 5.9 ± 2.3(P <.001)。软骨下囊肿在第四次随访时明显比第一次和第二次更差(P <.001,P =.006)。在第三次和第四次随访时,FAOS 评分与 SCBH 评分之间呈正相关(r = 0.55,P <.001;r = 0.70,P <.001),而在第一次和第二次随访时则无相关性。
OLT 微骨折术后 SCB 在中期随访时并未恢复。总体 SCBH 评分随时间显著下降。值得注意的是,软骨下囊肿随时间持续恶化。此外,中期随访时的 SCBH 评分与临床结果呈正相关。SCB 的持续形态变化可能预示着微骨折术的长期失败。